Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effects of different dopamine agonists and antagonists on post-menopausal hot flushes.

Zichella L, Falaschi P, Fioretti P, Melis GB, Cagnacci A, Gambacciani M, Mancini S.

Maturitas. 1986 Oct;8(3):229-37.

PMID:
3784919
2.

Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.

Melis GB, Gambacciani M, Cagnacci A, Paoletti AM, Mais V, Fioretti P.

Obstet Gynecol. 1988 Nov;72(5):688-92.

PMID:
3140150
3.

Veralipride: alternative antidopaminergic treatment for menopausal symptoms.

David A, Don R, Tajchner G, Weissglas L.

Am J Obstet Gynecol. 1988 May;158(5):1107-15.

PMID:
2967034
4.

The safety of veralipride.

De Leo V, Morgante G, Musacchio MC, Faldini E, Delia A, Petraglia F.

Expert Opin Drug Saf. 2006 Sep;5(5):695-701. Review.

PMID:
16907659
5.

Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes.

Carretti N, Florio P, Reis FM, Comai S, Bertazzo A, Petraglia F.

Climacteric. 2010 Apr;13(2):141-6. doi: 10.3109/13697130903219208.

PMID:
20082603
6.

Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study.

Vercellini P, Sacerdote P, Trespidi L, Manfredi B, Panerai AE, Crosignani PG.

Fertil Steril. 1994 Nov;62(5):938-42.

PMID:
7926138
8.

[The alternative to hormonal treatment of menopausal vasomotor flushes: veralipride].

Wesel S, Bosuma WB.

Sem Hop. 1983 Mar 3;59(9):596-9. French.

PMID:
6304907
9.

Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women.

Verbeke K, Dhont M, Vandekerckhove D.

Maturitas. 1988 Oct;10(3):225-30.

PMID:
3185294
10.

Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.

Wesel S, Bourguignon RP, Bosuma WB.

Curr Med Res Opin. 1984;8(10):696-700.

PMID:
6327190
11.
12.

Veralipride for hot flushes during gonadotropin-releasing hormone agonist treatment.

Vercellini P, Vendola N, Colombo A, Passadore C, Trespidi L, Crosignani PG.

Gynecol Obstet Invest. 1992;34(2):102-4.

PMID:
1398260
13.

Veralipride-induced acute coronary syndrome unmasking a non-secreting pheochromocytoma.

Montemurro D, Rossi GP.

J Endocrinol Invest. 2006 Jul-Aug;29(7):650-2.

PMID:
16957415
14.

Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs.

Seeman MV.

Gynecol Endocrinol. 2015 Oct;31(10):751-4. doi: 10.3109/09513590.2015.1060957. Epub 2015 Aug 18. Review.

PMID:
26291819
15.
16.

Actual status of veralipride use.

Carranza-Lira S.

Clin Interv Aging. 2010 Sep 7;5:271-6. Review.

17.

[Veralipride in the treatment of hot flushes in the menopause].

Pasetto N, Piccione E, Baschieri L.

Rev Fr Gynecol Obstet. 1985 Feb 28;80(3):163-5. French.

PMID:
3922035
18.

Endocrinological basis of hot flushes.

Bider D, Mashiach S, Serr DM, Ben-Rafael Z.

Obstet Gynecol Surv. 1989 Jul;44(7):495-9. Review.

PMID:
2662075
19.

Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.

Melis GB, Cagnacci A, Gambacciani M, Paoletti AM, Moggi L, Fioretti P.

J Clin Endocrinol Metab. 1988 May;66(5):964-7.

PMID:
2834413
20.

Supplemental Content

Support Center